Romania vs Serbia: Cause of death, by non-communicable diseases, ages 60+, female
Romania
77.0%
in 2021
Serbia
77.1%
in 2021
Romania rank
78th
Serbia rank
76th
Cause of death, by non-communicable diseases, ages 60+, female over time
- Romania
- Serbia
How they compare
Serbia currently reports 77.1% against 77.0% in Romania, a difference of 0.1%.
Across all 6 years both countries report, Serbia has been ahead every year.
Romania ranks 78th and Serbia ranks 76th of 185 countries.
Serbia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Romania | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 96.6% | 97.0% | 0.5% | Serbia |
| 2010s | 95.9% | 96.8% | 0.9% | Serbia |
| 2020s | 81.1% | 83.3% | 2.2% | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Romania or Serbia?
- Serbia, at 77.1% against 77.0% in Romania as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Romania and Serbia?
- 0.1%, with Serbia ahead.
- How many years of comparable data are there for Romania and Serbia?
- 6 years are reported by both, from 2000 to 2021.
- How do Romania and Serbia rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Romania ranks 78th and Serbia ranks 76th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.